Ted Shih

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies
    Ted Shih
    Department of Pharmacotherapy and Experimental Therapeutics, University of North Carolina School of Pharmacy, Chapel Hill, USA
    Clin Ther 28:1779-802. 2006

Detail Information

Publications1

  1. ncbi Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies
    Ted Shih
    Department of Pharmacotherapy and Experimental Therapeutics, University of North Carolina School of Pharmacy, Chapel Hill, USA
    Clin Ther 28:1779-802. 2006
    ....